Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden

• Published in: Osteoporosis international 2023-02, Vol.34 (2), p.349-356
• Main Authors: Sumrein, Bakir O., Berg, Hans E., Launonen, Antti P., Landell, Peter, Laitinen, Minna K., Felländer-Tsai, Li, Mattila, Ville M., Huttunen, Tuomas T.
• Format: Article
• Language: English
• Subjects: Adult; Age groups; Aged; Aged, 80 and over; Endocrinology; Female; Fractures; Frailty; Hip Fractures; Humans; Humeral Fractures; Humerus; Male; Medicin och hälsovetenskap; Medicine; Medicine & Public Health; Mortality; Original; Original Article; Orthopedics; Rheumatology; Shoulder Fractures - epidemiology; Sweden - epidemiology
• ISSN: 0937-941X; 1433-2965; 1433-2965
• DOI: 10.1007/s00198-022-06612-7

Summary Little is known about survival after proximal humerus fracture. In this manuscript, we found the mortality to be high (almost four times higher than in age- and sex-matched controls). While frailty hip fracture has gained attention, we hope our manuscript will shed light on frailty proximal humerus fracture patients. Introduction Proximal humerus fractures (PHF) are common and occur mostly after the 6th decade of life. While mortality following PHF has been reported previously, mortality data after longer follow-up on a national level is lacking. Methods We obtained data from the Swedish Hospital Discharge Register (SHDR), on all adult patients (≥ 18 years) with a diagnosis of PHF (S42.2, S42.20, or S42.21) for the period between 2001 and 2016. We used the Swedish Cause of Death Register (SCDR) to investigate mortality in the fracture cohort. We compared the mortality of fracture patients with age- and sex-matched population-based mortality data obtained from Statistics Sweden. Results A total of 147 692 PHF patients were identified, with a male to female ratio of 1:3. The mean age was 69 years (range, 18 to 111). Most patients were treated non-surgically ( n  = 126,487, 86%). The crude mortality rate was 2.2% at 1 month, 4.1% at 3 months, 8.5% at 12 months, and 24% at 48 months after sustaining a PHF. Mortality increased with age; however, the standardized mortality rate (SMR) was highest among young patients. SMR was 5.4 in the 18- to 39-year age group, 3.9 in the 40- to 64-year age group, 1.8 in the 65–79-year age group, and 1.2 in the ≥ 80-year-old population. The age-adjusted SMR was 3.9 in the whole adult PHF population. Conclusion The mortality rate and SMR suggest that PHF patients are heterogeneous. Some older PHF patients may benefit from specialized care (e.g., orthogeriatric), and this should be evaluated in future studies.